Silver Book Fact

Effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset

A study of the  victims with effectiveness of treating ischemic strokert-PA within 3 hours of symptom onset showed a decrease in rehabilitation costs of $1.4 million and nursing home costs of $4.8 million, per 1,000 eligible rt-PA-treated patients.

Fagan S, Morgenstern L, Petitta A, Ward R, et al. Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke. Neurology. 1998; 50(4): 883-890. http://www.neurology.org/content/50/4/883.abstract

Reference

Title
Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke
Publication
Neurology
Publication Date
1998
Authors
Fagan S, Morgenstern L, Petitta A, Ward R, et al.
Volume & Issue
Volume 50, Issue 4
Pages
883-890
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Assuming that Medicare Part D covers about 37% of beneficiaries’ drug costs, it is estimated that providing post-myocardial infarction Medicare beneficiaries with full coverage for combination pharmcotherapy will save more…  
  • Eliminating out-of-pocket drug costs for combination pharmacotherapy for the 423,000 Americans with drug insurance who will experience their first myocardial infarction in 2006 would save 4,736 lives, and would save…  
  • Because of the advent of imaging and noninvasive testing, Americans who are asymptomatic are being diagnosed with established cardiovascular disease.  
  • Greater use of clot-busting drug t-PA in ischemic stroke patients could save the health care system over $100 million a year.  
  • According to the National Center for Health Statistics, if all major forms of cardiovascular disease were eliminated, life expectancy would rise by close to 7 years.